<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01988441</url>
  </required_header>
  <id_info>
    <org_study_id>102066-F</org_study_id>
    <nct_id>NCT01988441</nct_id>
  </id_info>
  <brief_title>The Influence of Autophagy on Fatty Liver</brief_title>
  <official_title>The Influence of Autophagy on Nonalcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Far Eastern Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Science and Technology, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Far Eastern Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver&#xD;
      disease worldwide. It is not known why only some obese subjects develop NAFLD. In recent&#xD;
      years, a growing body of evidence showed a crucial role of autophagy in in the regulation of&#xD;
      liver fat storage. The purpose of this study is to determine whether autophagy&#xD;
      pathway-related genetic polymorphisms affect NAFLD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will perform a prospective comparison of the genotype distribution of&#xD;
      autophagy pathway-related genetic polymorphisms between those with and without NAFLD in a&#xD;
      cohort of obese children and adolescents.&#xD;
&#xD;
      [Subjects] Obesity is defined as the BMI value &gt; 95 percentile by different age- and gender&#xD;
      groups according to the standards of the Department of Health in Taiwan.&#xD;
&#xD;
      [Data collection] The following data were obtained for each subject: age, gender, BMI, waist&#xD;
      and hip circumference. The investigators will measure total serum bilirubin, alanine&#xD;
      aminotransferase, aspartate aminotransferase, γ-glutamyltransferase fasting glucose,&#xD;
      triglyceride, total cholesterol, and high-density lipoprotein cholesterol, insulin, glucose,&#xD;
      and adiponectin.&#xD;
&#xD;
      [Liver ultrasonography] All participants will receive an ultrasonographic study of the liver.&#xD;
      NAFLD is defined as the presence of an ultrasonographic pattern consistent with the following&#xD;
      criteria: liver-kidney echo discrepancy, attenuated echo penetration and visibility of&#xD;
      diaphragm, and obscure hepatic vessel structures.&#xD;
&#xD;
      [Genotyping] Genomic DNA will be extracted from 3 cc venous blood from each participant.&#xD;
      After extraction, the genomic DNA will be immediately stored at -80°C. The TaqMan genotyping&#xD;
      assays will be performed for selected SNPs genotyping on ABI 7300 Real-Time PCR System&#xD;
      (Applied Biosystems).&#xD;
&#xD;
      [Sample size] Sample size was estimated by Epi InfoTM 7 (CDC, USA) program. Because there was&#xD;
      no previous data regarding to the effect of autophagy related gene on NAFLD, the&#xD;
      investigators estimate the odds ratio to vary between 60-80%. The investigators used a&#xD;
      confidence level of 95%, power of 80%, the ratio of controls to NAFLD cases of 25%, percent&#xD;
      of controls exposed of 25-35%, the samples size required would be a total of 291-872&#xD;
      subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">August 2025</completion_date>
  <primary_completion_date type="Anticipated">August 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>The genotype distribution of autophagy pathway-related genetic polymorphisms between those with and without NAFLD</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Non-alcoholic Fatty Liver Disease</condition>
  <condition>Obesity</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum, WBC DNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Obese Taiwanese children and adolescents&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Age 6-18 years old&#xD;
&#xD;
          -  Obesity definition: BMI &gt; 95% according to the age- and gender-specific standard by&#xD;
             National Health Institute in Taiwan&#xD;
&#xD;
          -  Willing to give written informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Alcohol consumption&#xD;
&#xD;
          -  Chronic liver diseases, including hepatitis B, hepatitis C, Wilson disease and&#xD;
             autoimmune hepatitis&#xD;
&#xD;
          -  Major systemic diseases, including cardiopulmonary disease, renal failure, cancer, and&#xD;
             psychotic disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Cheng Lin, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Far Eastern Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu-Cheng Lin, M.D., Ph.D.</last_name>
    <phone>+886-89667000</phone>
    <phone_ext>1538</phone_ext>
    <email>q92421006@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Far Eastern Memorial Hospital</name>
      <address>
        <city>New Taipei City</city>
        <zip>220</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Cheng Lin, M.D., Ph.D.</last_name>
      <phone>886-89667000</phone>
      <phone_ext>4449</phone_ext>
      <email>q92421006@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Yu-Cheng Lin, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 7, 2013</study_first_submitted>
  <study_first_submitted_qc>November 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2013</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>autophagy</keyword>
  <keyword>children</keyword>
  <keyword>polymorphism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

